Hatfield, Kimberley J <br/><br/>
Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies.  [electronic resource] 

 -  Current cancer drug targets  Jun 2005 
 - 229-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1568-0096 
<br/><br/><label>Standard No.: </label>10.2174/1568009054064651  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--physiology<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Humans<br/>Interleukin-8--metabolism<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Vascular Endothelial Growth Factor A--drug effects